Eterna Therapeutics
ERNA
#10372
Rank
A$10.31 M
Marketcap
A$1.31
Share price
-25.80%
Change (1 day)
-85.04%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2025 (TTM): A-$111.33

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is A-$109.60. In 2022 the company made an earnings per share (EPS) of A-$179.81 an increase over its 2021 EPS that were of A-$1,188.

EPS history for Eterna Therapeutics from 2021 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$111.33
2022A-$179.81-84.86%
2021A-$1,188

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
A$5.29-104.83%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
A-$0.94-99.14%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
A-$2.89-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
A-$0.17-99.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
A$0.90-100.82%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
A$0.71-100.65%๐Ÿ‡บ๐Ÿ‡ธ USA